Our findings suggest that the observed increase in FLI1 expression in PTSD PBMCs (Figure 1) may contribute to elevated systemic inflammatory mediators and exacerbate inflammation within the brain by activating resident immune cells, such as microglia. The gene discussed is FLI1; the disease is post-traumatic stress disorder.